Catalyst Event
Globus Medical Inc (GMED) · Other
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
6/3/2026, 12:00:00 AM
Stockholders approved an amendment to the 2021 Equity Incentive Plan on 2026-06-03, increasing authorized shares by 1,000,000 to a total of 12,000,000; as this is a routine corporate governance matter, low impact expected
Korean Translation
2026년 6월 3일 연례 주주총회에서 2021년 주식 인센티브 계획 수정안을 승인하여 발행 가능 주식 수를 1,000,000주 증가한 총 12,000,000주로 확대함. 통상적인 경영 사항이므로 낮은 영향이 예상됨
Related Recent Events
Ambu A/S (AMBUB) · Earnings Release
Q3 2025/26 earnings release scheduled. (Low importance estimated for a routine scheduled event).
8/26/2026, 12:00:00 AM
Boston Scientific Corp (BSX) · Earnings Release
Q2 2026 earnings results and conference call for July 29, 2026, before market open scheduled
7/29/2026, 12:00:00 AM
Integer Holdings Corp (ITGR) · Earnings Release
Analysts forecast the next quarterly earnings release for 2026-07-23 estimated. Estimated Medium importance as earnings reports typically drive significant price volatility.
7/23/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Earnings Release
Alphabet Q2 2026 earnings release scheduled for July 22, 2026, with analysts forecasting EPS of approximately $2.85-$2.87 forecasted.
7/22/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Abbott is expected to announce its Q2 2026 earnings results on July 16, 2026. This key quarterly financial update is estimated to have a moderate price impact of at least 5%, scheduled.
7/16/2026, 12:00:00 AM
Pharmaron Beijing Co Ltd (3759) · Other
The ex-dividend date for the RMB 0.20 per share final dividend on July 7, 2026, with payment on August 7, 2026; market reaction is estimated at Low as the payout is within expected ranges scheduled.
7/7/2026, 12:00:00 AM